Latest From Biotech Now

BIO Supports SBIR Reauthorization in Senate

Capitol

Last week, the Senate passed the National Defense Authorization Act (S. 1867), which included SBIR reauthorization through Senate Amendment 1115. This is a critical step toward ensuring that all innovative companies can compete for SBIR grants – based on the promise of their science rather than the structure of their capital.  Reauthorizing the program to allow small companies that receive the majority of their financing from venture capital to once again be eligible to compete Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

4 Keys for Partnering Success

BIO Exhibition - 2011 BIO International Convention

Thinking of hosting partnering meetings at your BIO Exhibition booth in 2012? Abbott has been there, done that and learned what it takes to succeed and secure high-quality leads. “The greatest value of hosting partnering meetings within our booth is that it allows us to drive traffic, activity and interest within our own space,” said Michelle Calhoun, Abbott’s contract manufacturing marketing director. Abbott hosted nearly 60 meetings within our booth during three days of partnering Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Start 2012 with BIO – in Osaka!

osaka skyline

With BIO’s Fall events behind us, the team here quickly shifted focus to 2012! On January 31st, the BIO Asia International Conference will commence its ninth year!  What’s something new about the conference?  It’s moved!  Originally, BIO Asia was hosted in Tokyo, but the event has relocated for the first time and will now be held in Osaka, Japan.  We’re very excited about being in this city, which is Japan’s third largest, and is well-known Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Exclusive Licenses Do Not Discourage Follow On Research

medical_research_thumb

A recent study presented at the Patent Statistics for Decision Makers Conference organized at the United States Patent Office questions the logic behind a nonexclusive license preference often found in U.S. government technology transfer policy. In “The Role of Exclusive Licensing in Follow-on Research of Academic Patented Inventions” presentation the authors demonstrate that, contrary to the belief by some, exclusive licensing does not impede future research. The authors ask two questions.  First, does exclusive licensing affect licensee follow-on research?  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

15 Keys to Success from Fierce Biotech’s Top 15 Women in Biotech

lab_tech

This week, Fierce Biotech recognized 15 women who are leading the way in biotech. Each of them represents the drive and determination that it takes to succeed in the industry, but what do they recommend beyond these inherent qualities? We pulled together the list below based on their profiles so that others can learn from their experience (yes, that made the list). In no particular order: 1. Take risks 2. Have an entrepreneurial spirit 3. Read More >

Business of Biotech  |  1 Comment  |  Email This Post
Tags: ,